Mengyao Sun

China University of Mining and Technology

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer”.

PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer

Scientific Reports(2020)10.1038/s41598-020-72942-3

N/A

0DataRank · unranked

87 citations

Benlian Wang, Rasika Mundade, Guanglong Jiang, Mengyao Sun, Wei Han +4 more

Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer

Biomolecules(2020)10.3390/biom11010015

N/A

0DataRank · unranked

41 citations

Matthew Martin, Mengyao Sun, Tao Lu, Aishat Motolani

Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21103684

N/A

0DataRank · unranked

38 citations

Benlian Wang, Guanglong Jiang, Wei Han, Mengyao Sun, Lakshmi Prabhu +6 more

The Structure and Functions of PRMT5 in Human Diseases

Life(2021)10.3390/life11101074

N/A

0DataRank · unranked

65 citations

Matthew Martin, Mengyao Sun, Tao Lu, Aishat Motolani

The Pivotal Player: Components of NF-κB Pathway as Promising Biomarkers in Colorectal Cancer

International Journal of Molecular Sciences(2021)10.3390/ijms22147429

N/A

0DataRank · unranked

34 citations

Mengyao Sun, Aishat Motolani, Tao Lu, Matthew Martin

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

Genes & Diseases(2022)10.1016/j.gendis.2022.04.001

N/A

0DataRank · unranked

16 citations

Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang +13 more

PRMT5 is a therapeutic target in choroidal neovascularization

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.30.486275

N/A

0DataRank · unranked

0 citations

Matthew Martin, Mengyao Sun, Kamakshi Sishtla, Nathan R. Jensen, Aishat Motolani +6 more

PRMT5 is a therapeutic target in choroidal neovascularization

Scientific Reports(2023)10.1038/s41598-023-28215-w

N/A

0DataRank · unranked

11 citations

Matthew Martin, Kamakshi Sishtla, Aishat Motolani, Mengyao Sun, Nathan R. Jensen +6 more